Europe — EMA
Lamivudine Teva Pharma B.V
GNH USA supplies Lamivudine Teva Pharma B.V (Lamivudine), a nucleoside reverse transcriptase inhibitor for HIV infection and chronic hepatitis B.
Request sourcing
What is Lamivudine?
Lamivudine, the active ingredient in Lamivudine Teva Pharma B.V, is a nucleoside reverse transcriptase inhibitor (NRTI) presented as an oral tablet for oral use. It treats HIV infection and chronic hepatitis B in adult patients. The medication belongs to the antiretroviral therapeutic class and is administered under prescription.
GNH USA supplies Lamivudine Teva Pharma B.V as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with a focus on quality assurance and regulatory compliance.
What is Lamivudine used for?
Lamivudine is used in the management of viral infections that involve reverse transcriptase activity.
- Human Immunodeficiency Virus (HIV) infection: reduces viral load and slows disease progression. - Chronic hepatitis B infection: suppresses HBV DNA replication and improves liver function. - HIV/HBV co‑infection: provides dual antiviral activity against both viruses.
What are the side effects of Lamivudine?
Lamivudine may cause a range of adverse reactions, most of which are mild and reversible.
Common Side Effects: - Nausea - Headache - Fatigue - Diarrhea
Serious or Rare Side Effects: - Lactic acidosis - Severe hepatotoxicity - Pancreatitis
What precautions apply to Lamivudine?
Before prescribing lamivudine, clinicians should consider several safety factors.
- Renal function: assess baseline and monitor periodically. - Hepatic impairment: use with caution and check liver enzymes regularly. - Pregnancy: evaluate risk versus benefit; data are limited. - Concomitant antiretrovirals: review for additive toxicity. - Adherence: maintain consistent dosing to avoid resistance. - Store at room temperature: keep in the original container, protect from moisture and heat.
What does Lamivudine interact with?
Lamivudine can interact with other medicines, requiring careful management.
Major Interactions (Avoid): - Didanosine: increased risk of pancreatitis. - Stavudine: heightened mitochondrial toxicity. - Zidovudine: additive bone‑marrow suppression.
Moderate Interactions (Monitor Closely): - Rifampicin: reduces lamivudine plasma levels. - Efavirenz: may amplify central nervous system side effects.
Frequently asked questions
What conditions is Lamivudine Teva Pharma B.V used for?+
How does lamivudine work in the body?+
What is the usual dose of lamivudine?+
Is lamivudine safe during pregnancy or breastfeeding?+
How do I order Lamivudine Teva Pharma B.V from GNH USA?+
How does lamivudine compare with other antiretroviral drugs?+
What are the recommended storage conditions for lamivudine?+
How is lamivudine administered?+
What are the most serious risks associated with lamivudine?+
Who should not use lamivudine?+
Product details
Related products

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

A
Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo